Trevi Therapeutics, Inc.
NASDAQ:TRVI
3.5 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.176 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.038 | 0.035 | 0.035 | 0.035 | 0.034 | 0.019 | 0.015 | 0.009 | 0.008 | 0.011 | 0.012 | 0.013 | 0.012 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.038 | -0.035 | 0.141 | -0.035 | -0.034 | -0.019 | -0.015 | -0.009 | -0.008 | -0.011 | -0.012 | -0.013 | -0.012 | -0.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.801 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 10.021 | 8.804 | 6.518 | 6.323 | 5.842 | 5 | 4.317 | 5.769 | 5.103 | 4.645 | 6.179 | 4.718 | 6.498 | 5.589 | 6.56 | 4.828 | 4.921 | 6.019 | 4.823 | 5.65 | 5.528 | 3.338 | 4.523 | 3.747 | 3.439 | 2.363 | 1.598 |
| General & Administrative Expenses
| 3.268 | 3.102 | 2.415 | 2.722 | 2.54 | 2.563 | 2.339 | 2.636 | 2.717 | 2.38 | 2.094 | 2.229 | 2.669 | 2.5 | 2.633 | 2.416 | 2.492 | 2.62 | 1.943 | 2 | 1.889 | 1.474 | 1.406 | 1.21 | 0.941 | 0.779 | 0.611 |
| Selling & Marketing Expenses
| -0.038 | -0.035 | -0.035 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.013 |
| SG&A
| 3.23 | 3.067 | 2.38 | 2.722 | 2.54 | 2.563 | 2.339 | 2.636 | 2.717 | 2.38 | 2.094 | 2.229 | 2.669 | 2.5 | 2.633 | 2.416 | 2.492 | 2.62 | 1.943 | 2 | 1.889 | 1.474 | 1.406 | 1.21 | 0.941 | 0.779 | 0.624 |
| Other Expenses
| -0.005 | -0.001 | -0.003 | 0.154 | 0.153 | 1.155 | 1.132 | 0 | 0 | 0 | 0 | 0 | -0.375 | 0 | -0.313 | 0 | 0 | 0 | 0.225 | 0 | 0.066 | -0.052 | -0.148 | -0.749 | -0.49 | -0.856 | 0 |
| Operating Expenses
| 13.251 | 11.871 | 8.898 | 9.045 | 8.382 | 7.563 | 6.656 | 8.405 | 7.82 | 7.025 | 8.273 | 6.947 | 9.167 | 8.089 | 9.193 | 7.244 | 7.413 | 8.639 | 6.766 | 7.65 | 7.417 | 4.812 | 5.929 | 4.957 | 4.38 | 3.142 | 2.232 |
| Operating Income
| -13.289 | -11.906 | -8.933 | -9.045 | -8.382 | -7.563 | -6.656 | -8.405 | -7.82 | -7.025 | -8.273 | -6.947 | -9.167 | -8.089 | -9.193 | -7.244 | -7.413 | -8.639 | -6.766 | -7.65 | -7.417 | -4.812 | -5.929 | -4.957 | -4.38 | -3.142 | -2.222 |
| Operating Income Ratio
| 0 | 0 | -50.756 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.929 | 0.996 | 1.13 | 1.334 | 0.153 | 1.155 | 1.132 | 0.132 | -0.236 | -0.309 | 0.053 | -0.005 | -0.335 | -0.006 | -0.313 | -0.145 | 0.014 | 0.157 | 0.225 | 0.28 | 0.066 | -0.052 | -0.148 | -0.749 | -0.49 | -0.856 | -0.164 |
| Income Before Tax
| -12.36 | -10.91 | -7.803 | -7.711 | -7.175 | -6.408 | -5.524 | -8.273 | -8.056 | -7.334 | -8.526 | -7.253 | -9.796 | -8.386 | -9.506 | -7.389 | -7.399 | -8.482 | -6.541 | -7.37 | -7.351 | -4.806 | -6.031 | -5.679 | -4.883 | -4.076 | -2.386 |
| Income Before Tax Ratio
| 0 | 0 | -44.335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.008 | -0.008 | 0.018 | -0.013 | -0.03 | -0.007 | -0.02 | -0.007 | -0.004 | -0.005 | -0.006 | 0.002 | -0.002 | -0.015 | 0.017 | -0.011 | -0.015 | -0.009 | -0.004 | -0.005 | -0.005 | -0.004 | -0.049 | -0.025 | -0.025 | -0.025 | 0.008 |
| Net Income
| -12.352 | -10.902 | -7.821 | -7.698 | -7.145 | -6.401 | -5.504 | -8.266 | -8.052 | -7.329 | -8.52 | -7.255 | -9.794 | -8.371 | -9.523 | -7.378 | -7.384 | -8.473 | -6.537 | -7.365 | -7.346 | -4.802 | -5.982 | -5.654 | -4.858 | -4.051 | -3.485 |
| Net Income Ratio
| 0 | 0 | -44.438 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.12 | -0.11 | -0.079 | -0.078 | -0.072 | -0.065 | -0.056 | -0.12 | -0.14 | -0.24 | -0.39 | -0.34 | -0.49 | -0.43 | -0.51 | -0.41 | -0.41 | -0.48 | -0.37 | -0.41 | -0.41 | -0.27 | -0.34 | -0.63 | -0.54 | -0.45 | -8.05 |
| EPS Diluted
| -0.12 | -0.11 | -0.079 | -0.078 | -0.072 | -0.065 | -0.056 | -0.12 | -0.14 | -0.24 | -0.39 | -0.34 | -0.49 | -0.43 | -0.51 | -0.41 | -0.41 | -0.48 | -0.37 | -0.41 | -0.41 | -0.27 | -0.34 | -0.63 | -0.54 | -0.45 | -8.05 |
| EBITDA
| -13.251 | -11.871 | -8.898 | -9.045 | -6.99 | -7.563 | -6.656 | -8.061 | -7.721 | -7.127 | -7.903 | -7.05 | -9.528 | -8.073 | -9.193 | -7.228 | -7.402 | -8.629 | -6.766 | -7.359 | -7.417 | -4.797 | -6.018 | -5.675 | -4.828 | -3.951 | -2.221 |
| EBITDA Ratio
| 0 | 0 | -50.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |